A study of veliparib with carboplatin and paclitaxel and continued as maintenance treatment for ovarian cancer that has spread

This study looked at having veliparib with chemotherapy and then continuing it as maintenance treatment for ovarian cancer that has spread.

It included women with:

• ovarian cancer

• fallopian tube cancer

• primary peritoneal cancer

Doctors treat these cancers in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.

This study was open for women to join between 2015 and 2017. The team published the results in 2019.